Adherence to, and acceptability of, Listerine® mouthwash as a potential preventive intervention for pharyngeal gonorrhoea among men who have sex with men in Australia: a longitudinal studyVincent J. Cornelisse A B , Christopher K. Fairley A B , Sandra Walker A B , Tameka Young A , David Lee A B , Marcus Y. Chen A B , Catriona S. Bradshaw A B and Eric P. F. Chow A B C
A Melbourne Sexual Health Centre, Alfred Health, 580 Swanston Street, Carlton, Vic. 3053, Australia.
B Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, 89 Commercial Road, Melbourne, Vic. 3004, Australia.
C Corresponding author. Email: firstname.lastname@example.org
Sexual Health 13(5) 494-496 https://doi.org/10.1071/SH16026
Submitted: 21 January 2016 Accepted: 2 June 2016 Published: 22 July 2016
We investigated whether men who have sex with men (MSM) would use mouthwash daily to prevent pharyngeal gonorrhoea. Ten MSM attending the Melbourne Sexual Health Centre were asked to use a Listerine® alcohol-containing mouthwash daily for 14 days in August 2015. Mouthwash was used at least once daily for 133 of 140 person-days (95% of days; 95% confidence interval 90–98%). All 10 men were willing to use mouthwash on a daily basis, and nine men were willing to use mouthwash after oral sex. This study showed that daily use of mouthwash is an acceptable intervention to prevent pharyngeal gonorrhoea in MSM.
Additional keywords: gonorrhoea, Neisseria gonorrhoeae, oral sex, prevention, sexually transmissible infections.
References The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia. Sydney: The Kirby Institute, UNSW Australia; 2015.
 Chow EP, Tomnay J, Fehler G, Whiley D, Read TR, Denham I, Bradshaw CS, Chen MY, Fairley CK. Substantial increases in chlamydia and gonorrhea positivity unexplained by changes in individual-level sexual behaviors among men who have sex with men in an Australian sexual health service from 2007 to 2013. Sex Transm Dis 2015; 42 81–7.
| Substantial increases in chlamydia and gonorrhea positivity unexplained by changes in individual-level sexual behaviors among men who have sex with men in an Australian sexual health service from 2007 to 2013.CrossRef | 25585066PubMed |
 Skerlev M, Culav-Koscak I. Gonorrhea: new challenges. Clin Dermatol 2014; 32 275–81.
| Gonorrhea: new challenges.CrossRef | 24559563PubMed |
 Blomquist PB, Miari VF, Biddulph JP, Charalambous BM. Is gonorrhea becoming untreatable? Future Microbiol 2014; 9 189–201.
| Is gonorrhea becoming untreatable?CrossRef | 1:CAS:528:DC%2BC2cXjtVCksbw%3D&md5=7887caa48f61d8012af085c0cae7b7d9CAS | 24571073PubMed |
 Chow EP, Lee D, Tabrizi SN, Phillips S, Snow A, Cook S, Howden BP, Petalotis I, Bradshaw CS, Chen Y, Fairley CK. Detection of Neisseria gonorrhoeae in the pharynx and saliva: implications for gonorrhoea transmission. Sex Transm Infect 2016;
| Detection of Neisseria gonorrhoeae in the pharynx and saliva: implications for gonorrhoea transmission.CrossRef | 26941362PubMed |
 Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2012; 7 1401–22.
| Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.CrossRef | 1:CAS:528:DC%2BC38XhvVSqt7vN&md5=e2ca2d4c3d99a9b297b5de7b113a1730CAS | 23231489PubMed |
 Barrett-Connor E. The prophylaxis of gonorrhea. Am J Med Sci 1975; 269 4–11.
| The prophylaxis of gonorrhea.CrossRef | 1:STN:280:DyaE2M7mt1aiuw%3D%3D&md5=8500917f5e70df673cd9fc5586e53502CAS | 1093405PubMed |
 Levitt SD, Dubner SJ. Freakonomics: a rogue economist explores the hidden side of everything. New York: Harper Perennial; 2009.
 Feier I, Onisei D, Onisei D. Listerine in Romania – a new beginning. Med Evolution 2010; 16 79–82.